EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Persistent hyperprolactinemia after multimodal therapy in a pituitary macroadenoma: a case report

Luhut Suryanugraha, Suhendra Mandala Ernas, Eva Niamuzisilawati, Ferdy Royland Marpaung

Romanian Journal of Medical Practice · 30.09.2026 · 21 (3) · 256

DOI: 10.37897/rjmp.2026.3.8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Romanian Journal of Medical Practice, online erschienen am 30.09.2026. Verfasst von Luhut Suryanugraha und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary macroadenomas may present with reproductive disturbances that mimic physiological conditions such as pregnancy, thereby delaying diagnosis. A 33-year-old woman (G3P3A0) with previously regular menstrual cycles developed secondary amenorrhea after marriage and was initially presumed to be pregnant; repeated pregnancy tests and pelvic ultrasound examinations were negative. Hyperprolactinemia persisting for approximately two years eventually prompted pituitary imaging, which revealed a 2.9 × 2.5 × 1.9 cm cystic sellar–suprasellar macroadenoma. Because the preoperative prolactin concentration (90.23 ng/mL) was only moderately elevated relative to tumor size, stalk-effect hyperprolactinemia from a non-functioning adenoma was considered, and craniotomy with partial resection was performed in January 2024. Histopathology showed a benign pituitary adenoma; immunohistochemistry was not available. Postoperative computed tomography showed a residual hemorrhagic intrasellar lesion, subdural hematoma, subarachnoid hemorrhage, and cerebral edema, without neurological deficit. Prolactin decreased to 36.59 ng/mL in February 2024, normalized to approximately 23 ng/mL on bromocriptine 2.5 mg/day with resumption of menses, and the residual lesion was treated with fractionated radiotherapy in 28 fractions. In May 2024, prolactin rose to 46.29 ng/mL with recurrent amenorrhea and returned to approximately 23 ng/mL in June 2024 after bromocriptine was reinitiated. This case illustrates that prolactin should be measured early in unexplained secondary amenorrhea, that moderate hyperprolactinemia in a macroadenoma must be interpreted cautiously, and that serial prolactin measurement combined with imaging is required during long-term multidisciplinary follow-up.

Zitieren

APA

Suryanugraha, L., Ernas, S. M., Niamuzisilawati, E., & Marpaung, F. R. (2026). Persistent hyperprolactinemia after multimodal therapy in a pituitary macroadenoma: a case report. Romanian Journal of Medical Practice, 21(3), 256. https://doi.org/10.37897/rjmp.2026.3.8

Vancouver

Suryanugraha L, Ernas SM, Niamuzisilawati E, Marpaung FR. Persistent hyperprolactinemia after multimodal therapy in a pituitary macroadenoma: a case report. Romanian Journal of Medical Practice. 2026;21(3):256. doi:10.37897/rjmp.2026.3.8

BibTeX
@article{Suryanugraha2026,
  author = {Suryanugraha, Luhut and Ernas, Suhendra Mandala and Niamuzisilawati, Eva and Marpaung, Ferdy Royland},
  title = {Persistent hyperprolactinemia after multimodal therapy in a pituitary macroadenoma: a case report},
  journal = {Romanian Journal of Medical Practice},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {256},
  doi = {10.37897/rjmp.2026.3.8}
}
Kostenlos starten →